Perry C Siatis Abb Vie Inc. (ABBV) insider trading activity

ABBV Quotes by TradingView

Perry C Siatis is EVP, GC AND SECRETARY of AbbVie Inc.. Currently has a direct ownership of 4,619 shares of ABBV, which is worth approximately $936,363. The most recent transaction as insider was on Mar 03, 2025, when has been sold 18,008 shares (Common Stock, $0.01 par value) at a price of $210.0 per share, resulting in proceeds of $3,781,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.62K
55.57% 3M change
55.57% 12M change
Total Value Held $936,363

Perry C Siatis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Open market or private sale
$3,781,680 $210.0 p/Share
18,008 Reduced 79.59%
4,619 Common Stock, $0.01 pa...
Mar 03 2025
BUY
Exercise of conversion of derivative security
$2,817,891 $156.48 p/Share
18,008 Added 44.32%
22,627 Common Stock, $0.01 pa...
Feb 28 2025
SELL
Open market or private sale
$2,041,708 $206.4 p/Share
9,892 Reduced 68.17%
4,619 Common Stock, $0.01 pa...
Feb 28 2025
SELL
Payment of exercise price or tax liability
$1,613,507 $205.02 p/Share
7,870 Reduced 35.16%
14,511 Common Stock, $0.01 pa...
Feb 20 2025
SELL
Open market or private sale
$1,142,657 $197.76 p/Share
5,778 Reduced 20.52%
22,381 Common Stock, $0.01 pa...
Feb 13 2025
BUY
Grant, award, or other acquisition
-
17,762 Added 38.68%
28,159 Common Stock, $0.01 pa...
Feb 29 2024
SELL
Open market or private sale
$1,756,048 $177.54 p/Share
9,891 Reduced 48.75%
10,397 Common Stock, $0.01 pa...
Feb 28 2024
SELL
Payment of exercise price or tax liability
$1,411,336 $178.99 p/Share
7,885 Reduced 27.99%
20,288 Common Stock, $0.01 pa...
Feb 23 2024
SELL
Open market or private sale
$2,441,295 $177.51 p/Share
13,753 Reduced 32.8%
28,173 Common Stock, $0.01 pa...
Feb 23 2024
BUY
Exercise of conversion of derivative security
$1,834,100 $133.36 p/Share
13,753 Added 24.7%
41,926 Common Stock, $0.01 pa...
Feb 15 2024
BUY
Grant, award, or other acquisition
-
17,796 Added 38.71%
28,173 Common Stock, $0.01 pa...
Feb 02 2024
SELL
Sale (or disposition) back to the issuer
$496,230 $170.0 p/Share
2,919 Reduced 21.95%
10,377 Common Stock, $0.01 pa...
Feb 02 2024
BUY
Grant, award, or other acquisition
$421,912 $144.54 p/Share
2,919 Added 18.0%
13,296 Common Stock, $0.01 pa...
Apr 03 2023
SELL
Open market or private sale
$563,200 $160.0 p/Share
3,520 Reduced 25.33%
10,377 Common Stock, $0.01 pa...
Apr 03 2023
BUY
Exercise of conversion of derivative security
$372,838 $105.92 p/Share
3,520 Added 20.21%
13,897 Common Stock, $0.01 pa...
Mar 01 2023
SELL
Open market or private sale
$1,859,324 $153.22 p/Share
12,135 Reduced 53.9%
10,377 Common Stock, $0.01 pa...
Feb 28 2023
SELL
Payment of exercise price or tax liability
$1,489,727 $154.28 p/Share
9,656 Reduced 30.02%
22,512 Common Stock, $0.01 pa...
Feb 21 2023
SELL
Open market or private sale
$1,112,037 $151.01 p/Share
7,364 Reduced 18.63%
32,168 Common Stock, $0.01 pa...
Feb 21 2023
BUY
Exercise of conversion of derivative security
$688,534 $93.5 p/Share
7,364 Added 15.7%
39,532 Common Stock, $0.01 pa...
Feb 16 2023
BUY
Grant, award, or other acquisition
-
21,791 Added 40.38%
32,168 Common Stock, $0.01 pa...
PCS

Perry C Siatis

EVP, GC AND SECRETARY
North Chicago, IL

Track Institutional and Insider Activities on ABBV

Follow AbbVie Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABBV shares.

Notify only if

Insider Trading

Get notified when an Abb Vie Inc. insider buys or sells ABBV shares.

Notify only if

News

Receive news related to AbbVie Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABBV